KR101498075B1 - Composition and health functional food containing extracts of sorghum bran - Google Patents
Composition and health functional food containing extracts of sorghum bran Download PDFInfo
- Publication number
- KR101498075B1 KR101498075B1 KR1020130092788A KR20130092788A KR101498075B1 KR 101498075 B1 KR101498075 B1 KR 101498075B1 KR 1020130092788 A KR1020130092788 A KR 1020130092788A KR 20130092788 A KR20130092788 A KR 20130092788A KR 101498075 B1 KR101498075 B1 KR 101498075B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- antioxidant
- health functional
- activity
- functional food
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 120
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 230000036541 health Effects 0.000 title claims abstract description 33
- 235000013376 functional food Nutrition 0.000 title claims abstract description 25
- 235000011684 Sorghum saccharatum Nutrition 0.000 title description 14
- 240000006394 Sorghum bicolor Species 0.000 title description 13
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 115
- 239000003963 antioxidant agent Substances 0.000 claims description 54
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 46
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 42
- 238000000605 extraction Methods 0.000 claims description 39
- 241001070941 Castanea Species 0.000 claims description 27
- 235000014036 Castanea Nutrition 0.000 claims description 27
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 27
- 235000013824 polyphenols Nutrition 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 22
- 239000002904 solvent Substances 0.000 claims description 21
- 235000018553 tannin Nutrition 0.000 claims description 15
- 239000001648 tannin Substances 0.000 claims description 15
- 229920001864 tannin Polymers 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 8
- 229930003935 flavonoid Natural products 0.000 claims description 8
- 150000002215 flavonoids Chemical class 0.000 claims description 8
- 235000017173 flavonoids Nutrition 0.000 claims description 8
- 238000005516 engineering process Methods 0.000 claims description 6
- 230000002068 genetic effect Effects 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims description 2
- 235000016623 Fragaria vesca Nutrition 0.000 claims 1
- 240000009088 Fragaria x ananassa Species 0.000 claims 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims 1
- 238000000527 sonication Methods 0.000 claims 1
- 235000008708 Morus alba Nutrition 0.000 abstract description 11
- 240000000249 Morus alba Species 0.000 abstract description 11
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 7
- 240000006439 Aspergillus oryzae Species 0.000 abstract description 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 abstract description 2
- 235000006708 antioxidants Nutrition 0.000 description 43
- 230000000052 comparative effect Effects 0.000 description 32
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 24
- 238000004519 manufacturing process Methods 0.000 description 22
- 239000013543 active substance Substances 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 11
- 150000003254 radicals Chemical class 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 235000013361 beverage Nutrition 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- -1 lipid peroxides Chemical class 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 238000002137 ultrasound extraction Methods 0.000 description 7
- 206010057190 Respiratory tract infections Diseases 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 239000000469 ethanolic extract Substances 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 241000254171 Curculionidae Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 235000017879 Nasturtium officinale Nutrition 0.000 description 4
- 240000005407 Nasturtium officinale Species 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 102000016938 Catalase Human genes 0.000 description 3
- 108010053835 Catalase Proteins 0.000 description 3
- 244000058871 Echinochloa crus-galli Species 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 244000062793 Sorghum vulgare Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000000401 methanolic extract Substances 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 2
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- 235000007542 Cichorium intybus Nutrition 0.000 description 2
- 244000298479 Cichorium intybus Species 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 241001632410 Eleutherococcus senticosus Species 0.000 description 2
- 235000013418 Myrtus communis Nutrition 0.000 description 2
- 240000005125 Myrtus communis Species 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 235000015505 Sorghum bicolor subsp. bicolor Nutrition 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 230000005714 functional activity Effects 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000002035 hexane extract Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 229930013915 (+)-catechin Natural products 0.000 description 1
- 235000007219 (+)-catechin Nutrition 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 241000269837 Artemisia dubia Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 208000001640 Fibromyalgia Diseases 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 241000209082 Lolium Species 0.000 description 1
- 206010050017 Lung cancer metastatic Diseases 0.000 description 1
- 240000003394 Malpighia glabra Species 0.000 description 1
- 235000014837 Malpighia glabra Nutrition 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- RPDUDBYMNGAHEM-UHFFFAOYSA-N PROXYL Chemical group CC1(C)CCC(C)(C)N1[O] RPDUDBYMNGAHEM-UHFFFAOYSA-N 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 244000062720 Pennisetum compressum Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 240000003296 Petasites japonicus Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004159 Potassium persulphate Substances 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 235000007230 Sorghum bicolor Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000003811 acetone extraction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 201000007455 central nervous system cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229940069647 citric acid 1000 mg Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 230000000683 nonmetastatic effect Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- CMFNMSMUKZHDEY-UHFFFAOYSA-N peroxynitrous acid Chemical compound OON=O CMFNMSMUKZHDEY-UHFFFAOYSA-N 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 235000019394 potassium persulphate Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000006318 protein oxidation Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229940119485 safflower extract Drugs 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000000323 shoulder joint Anatomy 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 수수 겨 추출물을 포함하고 항산화 활성을 갖는 조성물에 관한 것으로서, 보다 상세하게는 수수의 통곡 추출물 또는/및 수수의 알곡 추출물보다 항산화 활성이 뛰어난 수수의 겨 추출물을 포함하여 항산화 활성이 향상된 항산화제용 약학적 조성물 및/또는 건강 기능성 식품에 관한 것이다.More particularly, the present invention relates to a composition having an antioxidative activity, which comprises an extract of Aspergillus oryzae, which has an antioxidative activity higher than that of a mulberry extract or / and a mulberry extract, Pharmaceutical compositions and / or health functional foods.
Description
본 발명은 수수 겨 추출물을 포함하고 항산화 활성을 갖는 조성물에 관한 것으로서, 보다 상세하게는 수수의 통곡 추출물 또는/및 수수의 알곡 추출물보다 항산화 활성이 뛰어난 수수의 겨 추출물을 포함하여 항산화 활성이 향상된 항산화제용 약학적 조성물 및/또는 건강 기능성 식품에 관한 것이다.More particularly, the present invention relates to a composition having an antioxidative activity, which comprises an extract of Aspergillus oryzae, which has an antioxidative activity higher than that of a mulberry extract or / and a mulberry extract, Pharmaceutical compositions and / or health functional foods.
수수(Sorghum bicolor L. Moench, sorghum)는 외떡잎식물 벼목 화본과의 한해살이풀로 주로 식용으로 소비되고 있다. 열대아프리카가 원산지로 건조지대에서 가장 많이 재배되고 용도에 따라서 곡용수수(grain sorghum), 단수수(sorgo), 소경수수(장목수수; broom-corn)가 재배되고 있으며, 아시아, 아프리카 및 중미 지역에서 재배되고 있는 식량자원이다. 수수는 세계적으로 생산량이 57,772 천톤으로 곡류 중에서 쌀, 보리, 밀, 옥수수에 이어 5위를 기록하고 있으며, 식이섬유, 페놀화합물(phenolic compounds) 등의 유효성분이 다량 함유되어 있다. 페놀화합물은 축합형 탄닌(Condensed tannin), 플라보노이드(Flavonoid), 페놀산(Phenolic acid) 등으로 구성되어 있고, 대부분은 플라보노이드(flavonoid)로 알려져 있다. 이러한 파이토케미칼들은 인체에 유익한 다양한 건강기능 활성을 나타내는 것으로 알려져 있는데 수수의 폴리페놀(polyphenol) 추출물은 강한 항돌연변이성을 가지는 것으로 보고되었다. Sorghum (Sorghum bicolor L. Moench, sorghum) is a perennial herb that has been consumed mainly for edible purposes. Tropical Africa is the country's most cultivated land in the arid region and cultivated as grain sorghum, sorgo and broom-corn depending on the application, and in Asia, Africa and Central America It is a food resource being cultivated. Syrup is the world's fifth largest producer of rice, barley, wheat and corn in the world with a production of 57,772,000 tons. It contains a large amount of active ingredients such as dietary fiber and phenolic compounds. Phenolic compounds are composed of Condensed tannin, Flavonoid, Phenolic acid, and most of them are known as flavonoids. These phytochemicals are known to exhibit a variety of health functional activities beneficial to the human body. Polyphenol extracts of Acerola have been reported to have strong antimutagenic properties.
또한, 수수에 있는 페놀릭 성분(phenolic compound)은 품종에 따라 함량의 정도가 매우 다양하고, 나타내는 건강 기능 활성도 다양한 것으로 보고되고 있다. 종래에는 국내산 토종수수 22품종을 대상으로 전자공여능, 환원력, 항균활성 및 알파-글루코시다아제(α-glucosidase) 저해활성을 비교해본 결과, 품종간 생리활성의 차이가 커서 메수수, 붉은장목수수 추출물이 BHT, BHA와 같은 합성 항산화제보다도 전자공여능이 컸다는 보고가 있다. 또한, 종래 연구에서는 25종의 수수를 메탄올 추출하여 순차적 용매 분획한 후 항산화 및 항균활성을 검정한 결과 수수종류에 따라 활성이 매우 다양하게 나타났다고 보고하여 품종간 기능성의 차이를 보고한 바 있다.In addition, the phenolic compounds in the sorghum have varying degrees of content depending on the variety and have been reported to exhibit various health functional activities. As a result of comparing the electron donating ability, reducing power, antimicrobial activity and α-glucosidase inhibitory activity of 22 domestic varieties, the difference in the physiological activity between varieties was large, Has a higher electron donating ability than synthetic antioxidants such as BHT and BHA. In addition, in the previous studies, 25 kinds of sorghum were extracted with methanol, and the antioxidative and antimicrobial activities were tested after sequential solvent fractionation. As a result, the activity varied according to the species of sorghum.
항산화(antioxidation)란 체내에서 일어나는 여러 산화작용을 방지하는 것을 말한다. 산화작용은 체내에 존재하는 여러 종류의 불포화 지방산이 산소에 의해 산화되면 과산화 지질이라고 하는 물질이 생성되고 이것이 증가하면 노화 현상이 촉진되는 현상을 말한다. 인간의 질병 및 노화는 체내 대사과정 중 발생하는 O2 -(superoxide), NO·(nitric oxide), NO2·(nitrogen dioxide), OH·(hydroxyl), ROO·(proxyl), RO·(alkoxyl), NO3·(peroxynitrite) 라디칼(radical) 등의 산화반응에 기인하며 생체 내에서는 이런 유해한 라디칼인 유리기로부터 생체를 방어하기 위한 수단으로써 수퍼옥사이드 디스무타제(SOD, superoxide dismutase), 카탈라제(CAT; catalase), 글루타치온 퍼옥시다제(GSHpx; glutathione peroxidase) 등의 항산화 효소나 비타민 E, 글루타치온 등의 항산화 물질이 존재하여 유리기를 제거함으로써 생체를 산화적 손상으로부터 보호한다. 그러나 이러한 항산화 방어계가 유리기 생성을 조절할 수 없을 정도로 저하될 때 조직의 산화적 스트레스와 손상이 촉진되며 체내에서 생성된 과잉의 유리기와 지질 과산화물은 단백질의 산화, DNA 손상과 같은 산화적 스트레스에 의한 상해를 증가시킨다. 그러므로 이러한 산화적 스트레스의 감소를 위해 많은 항산화 물질이 개발되어 왔다.Antioxidation refers to the prevention of many oxidative effects in the body. Oxidation refers to the phenomenon that when various kinds of unsaturated fatty acids present in the body are oxidized by oxygen, a substance called lipid peroxidation is produced, and when it is increased, aging phenomenon is promoted. Human diseases and aging can be classified into O 2 - (superoxide), NO · (nitric oxide), NO 2 · (nitrogen dioxide), OH · (hydroxyl), ROO · (proxyl) , NO 3 · (peroxynitrite) radicals and the like. In vivo, superoxide dismutase (SOD), catalase (CAT) as a means for defending the living body from free radicals such as harmful radicals, catalase and antioxidant enzymes such as glutathione peroxidase (GSHpx) and vitamin E and glutathione are present to protect the living body from oxidative damage by eliminating free radicals. However, when such an antioxidant defense system declines to such an extent that free radical formation can not be controlled, the oxidative stress and damage of the tissue are promoted, and the excess free radicals and lipid peroxides produced in the body are oxidized by oxidative stress such as protein oxidation and DNA damage . Therefore, many antioxidants have been developed to reduce such oxidative stress.
이러한 항산화 물질은 피부염, 인후염, 편도염, 섬유근통, 류마티스 관절염, 견관절주위염, 근육염, 간염, 방광염, 신장염 등의 염증성 질환 예방, 노화방지, 피로 회복, 백혈병, 유방암, 결장암, 전립선암, 폐암, 안암, 피부암, 비세포성 폐암, 자궁암, 흑색동, 대장암, 중추신경계암 등의 암 질환을 예방하는 효과가 있다.Such antioxidants may be used for the prevention of inflammatory diseases such as dermatitis, sore throat, tonsillitis, fibromyalgia, rheumatoid arthritis, shoulder joint inflammation, myositis, hepatitis, cystitis and nephritis, aging, fatigue, leukemia, breast cancer, colon cancer, prostate cancer, Skin cancer, non-metastatic lung cancer, uterine cancer, black copper, colorectal cancer, and central nervous system cancer.
그러나, 종래의 합성 항산화제의 경우 항산화제로서 높은 항산화 활성을 보였으나, 약제로서 인체에 안전성의 문제가 있어, 최근에는 각종생약 또는 식용식물 추출물 등에서 보다 안전하며 항산화 효과가 뛰어난 천연 항산화제를 개발하기 위한 노력을 하고 있다. 하지만, 종래의 천연물 유래 항산화제는 인체에 안정성의 문제는 없으나, 항산화 활성이 낮아 약제로서 활용하기에 적합하지 않은 문제점이 있었다. However, the conventional synthetic antioxidants showed high antioxidative activity as an antioxidant. However, since they have a problem of safety to human body as a medicine, recently, they have developed a natural antioxidant which is more safe and has excellent antioxidative effect in various herbal medicines or edible plant extracts We are making efforts to do so. However, conventional antioxidants derived from natural products have no problem of stability to human body, but have low antioxidative activity and thus are not suitable for use as pharmaceuticals.
본 발명은 상기와 같은 문제점을 해결하기 위하여 안출된 것으로, 종래의 합성 항산화제보다 인체에 무해하며, 종래 천연물 유래 항산화제보다 향상된 항산화 활성을 갖는 항산화제 조성물을 제공하려는 목적이 있다. 또한, 수수 중 항산화 활성이 높은 부분을 포함하여 탄닌 및 폴리페놀의 함량이 높은 항산화제 조성물 및/또는 건강 기능성 식품을 제공하려는 목적이 있다.Disclosure of Invention Technical Problem [8] Accordingly, the present invention has been made to solve the above-mentioned problems, and it is an object of the present invention to provide an antioxidant composition which is more harmless to human body than conventional synthetic antioxidants and has improved antioxidative activity than natural- It is also an object of the present invention to provide an antioxidant composition and / or a health functional food having a high content of tannins and polyphenols, including a part having high antioxidative activity during transplantation.
본 발명은 수수 겨 추출물을 포함하는 항산화제 조성물을 제공한다.The present invention provides an antioxidant composition comprising a chafflet extract.
본 발명의 바람직한 일실시예에 따르면, 상기 수수 겨 추출물은 탄닌(tannin), 플라보노이드(flavonoid) 및 폴리페놀(polyphenol)로 이루어진 군 중 1종 이상을 포함할 수 있다.According to a preferred embodiment of the present invention, the chestnut extract may contain at least one of the group consisting of tannins, flavonoids and polyphenols.
본 발명의 바람직한 다른 일실시예에 따르면, 상기 항산화제 조성물 중량 중 수수 겨 추출물 10 ~ 70 중량%를 포함할 수 있다.According to another preferred embodiment of the present invention, the antioxidant composition may contain 10 to 70% by weight of the chestnut extract.
본 발명의 바람직한 또 다른 일실시예에 따르면, 상기 수수 겨 추출물은 농업 유전자원 센터에 기탁번호 KACC98013P인 수수의 겨 추출물일 수 있다.
According to another preferred embodiment of the present invention, the chopped chicory extract may be chestnut extract of Chrysanthemum morifolium, which is deposited at the National Institute of Agricultural Science and Technology of Korea, KACC98013P.
또한, 본 발명은 수수 겨 추출물을 포함하는 항산화 건강 기능성 식품을 제공한다.In addition, the present invention provides an antioxidant health functional food comprising a chaff endowed extract.
본 발명의 바람직한 일실시예에 따르면, 상기 수수 겨 추출물은 ABTS 라디칼 활성이 50 ~ 120 ㎎ 트로록스 당량(trolox equivalent)/ g 시료일 수 있다.According to a preferred embodiment of the present invention, the barnyardgrass extract may have an ABTS radical activity of 50-120 mg Trolox equivalent / g sample.
본 발명의 바람직한 다른 일실시예에 따르면, 상기 수수 겨 추출물은 탄닌(tannin) 10 ~ 30 ㎎ 및 폴리페놀(polyphenol) 20 ~ 80 ㎎를 포함할 수 있다.According to another preferred embodiment of the present invention, the chestnut extract may contain 10 to 30 mg of tannin and 20 to 80 mg of polyphenol.
본 발명의 바람직한 또 다른 일실시예에 따르면, 상기 항산화 건강 기능성 식품은 노화방지 또는 피로회복 활성을 가질 수 있다.According to another preferred embodiment of the present invention, the antioxidant health functional food may have antioxidant or fatigue recovery activity.
본 발명의 바람직한 또 다른 일실시예에 따르면, 상기 수수 겨 추출물은 농업 유전자원 센터에 기탁번호 KACC98013P인 수수의 겨 추출물일 수 있다.
According to another preferred embodiment of the present invention, the chopped chicory extract may be chestnut extract of Chrysanthemum morifolium, which is deposited at the National Institute of Agricultural Science and Technology of Korea, KACC98013P.
나아가, 본 발명은 수수 겨 및 추출 용매를 혼합하여 혼합물을 제조하는 1단계; 및 상기 혼합물에서 추출물을 추출하는 2단계; 를 포함하는 수수 겨 추출물 제조방법을 제공한다.Further, the present invention relates to a process for producing a mixture comprising: a first step of mixing a bran and an extraction solvent to prepare a mixture; And 2) extracting the extract from the mixture; ≪ RTI ID = 0.0 > a < / RTI >
본 발명의 바람직한 일실시예에 따르면, 상기 추출 용매는 물, 아세톤 및 저급 알코올로 구성된 군 중 1종 이상일 수 있다.According to a preferred embodiment of the present invention, the extraction solvent may be at least one kind selected from the group consisting of water, acetone and lower alcohol.
본 발명의 바람직한 다른 일실시예에 따르면, 상기 추출물을 추출하는 방법은 혼합물에 40 ~ 80 ㎐의 초음파로 1 ~ 5시간 동안 처리하는 것일 수 있다.
According to another preferred embodiment of the present invention, the method for extracting the extract may be performed by treating the mixture with ultrasound at 40 to 80 Hz for 1 to 5 hours.
이하, 본 발명의 용어를 설명한다.Hereinafter, terms of the present invention will be described.
본 발명의 "수수 겨"는 수수 이삭을 탈곡한 다음 알곡을 도정하는 과정에서 생기는 부산물을 의미하는 것으로, 알곡을 도정하는 과정에서 생성되는 모든 부산물을 포함할 수 있다.The term " harvested bran "of the present invention means a byproduct produced in the course of harvesting the harvested rice after harvesting the harvested rice, and may include all the byproducts generated during the harvesting.
본 발명의 "저급 알코올"은 C1 ~ C4 알코올로 이루어진 군 중 어느 1종 이상의 알코올을 의미한다.The "lower alcohol" of the present invention means any one or more of the group consisting of C 1 -C 4 alcohols.
본 발명은 수수의 겨 추출물을 포함하여 종래의 합성 항산화제보다 인체에 무해하며, 종래 천연물 유래 항산화제보다 향상된 항산화 활성을 갖는 항산화제 조성물을 제공하려는 목적이 있다. It is an object of the present invention to provide an antioxidant composition which is more harmless to human body than conventional synthetic antioxidants including antimicrobial extracts of sorghum and has antioxidative activity which is higher than antioxidants derived from natural materials in the past.
또한, 수수 중 항산화 활성이 높은 부분을 포함하여 탄닌 및 폴리페놀의 함량이 높은 항산화제 조성물 및/또는 건강 기능성 식품을 제공하려는 목적이 있다.It is also an object of the present invention to provide an antioxidant composition and / or a health functional food having a high content of tannins and polyphenols, including a part having high antioxidative activity during transplantation.
게다가, 항산화 활성 물질의 함량이 다양한 수수의 품종 중 항산화 활성 물질의 함량이 월등한 수수 품종을 제공할 수 있다.In addition, it is possible to provide a cultivar having an excellent content of antioxidative active substance among various cultivars having various contents of antioxidative active substances.
나아가, 종래에는 특별하게 사용되는 용도가 없어 폐기되었던 수수의 겨를 활용한다는 점에서 장점 및 항산화 활성을 갖는 항산화제용 약학적 조성물 및/또는 건강 기능성 식품을 제공할 수 있다.Furthermore, it is possible to provide a pharmaceutical composition for antioxidant and / or a health functional food having an advantage and antioxidative activity in that it has been used in the past because it has been used for a long time.
도 1은 실험예 1에서 측정한 ABTS 라디컬 소거활성 결과이다.
도 2는 실험예 2에서 측정한 폴리페놀, 탄닌 및 항산화 활성 결과이다.
도 3은 실험예 3-1에서 측정한 수수 겨 추출물의 항산화 활성 물질 함유량이다.
도 4는 실험예 3-2에서 측정한 수수 겨 추출물의 ABTS 항산화 활성 및 DPPH 항산화 활성 결과이다.
도 5는 실험예 4에서 측정한 수수 겨 추출물의 ABTS 항산화 활성 및 폴리페놀 함량 결과이다.FIG. 1 shows the results of ABTS radical scavenging activity measured in Experimental Example 1. FIG.
Fig. 2 shows the results of polyphenol, tannin and antioxidant activity measured in Experimental Example 2. Fig.
Fig. 3 shows the content of the antioxidative active substance of the mulberry bran extract as measured in Experimental Example 3-1.
Fig. 4 shows the ABTS antioxidant activity and DPPH antioxidant activity of the chestnut extract obtained in Experimental Example 3-2.
FIG. 5 shows the results of ABTS antioxidant activity and polyphenol content of the mulberry bran extract of Experimental Example 4.
이하, 본 발명을 더욱 상세히 설명한다.Hereinafter, the present invention will be described in more detail.
상술한 바와 같이, 수수는 곡물 중에서 폴리페놀과 항산화성분 함량이 가장 높아 항산화활성이 높은 작물로서 상기와 같이 수수의 건강기능성에 대한 연구가 다양하게 수행되고 있다. 하지만, 수수의 항산화활성을 산업적 측면에서 효과적으로 이용하기 위해서는 항산화활성이 더욱 탁월한 수수 추출물 또는 수수 가공품의 개발이 절실히 필요한 실정이다.
As described above, sorghum is the highest antioxidant activity of polyphenols and antioxidant components in cereals, and thus various studies on the health function of sorghum have been carried out as described above. However, in order to effectively utilize the antioxidative activity of sorghum in an industrial aspect, it is inevitable to develop a water extract or a processed product having superior antioxidant activity.
이에 본 발명은 수수 겨 추출물을 포함하는 항산화제용 약학적 조성물 및/또는 건강 기능성 식품을 제공하여, 수수의 항산화 활성을 산업적 측면에서 효과적으로 이용할 수 있는 방법을 제공하며, 종래의 특별한 용도가 없어 폐기되었던 수수의 겨를 활용한 장점 및 항산화 활성을 갖는 항산화제용 약학적 조성물 및/또는 건강 기능성 식품을 제공할 수 있다.
Accordingly, the present invention provides a pharmaceutical composition for antioxidants and / or a health functional food containing the chestnut extract and provides a method of effectively utilizing the antioxidative activity of citron in an industrial aspect, A pharmaceutical composition for antioxidants having an antioxidative activity and / or a health functional food can be provided.
본 발명의 항산화제 조성물 및/또는 건강 기능성 식품은 수수 겨 추출물을 포함한다.The antioxidant composition and / or the health functional food of the present invention include a cherry vinegar extract.
상기 수수 겨는 수수 이삭을 탈곡한 다음 알곡을 도정하는 과정에서 생기는 부산물을 의미하는 것으로, 알곡을 도정하는 과정에서 생성되는 모든 부산물을 포함할 수 있다.The above-mentioned harvested horse means a by-product generated in the process of threshing the harvested ear and then grinding the grain, and may include all the by-products generated in the process of harvesting the grain.
도 1에서 확인되는 바와 같이, 상술한 바와 같은 수수 겨를 사용하여 추출물을 수득한 경우, ABTS(2,2'-Azino-bis-3-ethylbenzo- thiazoline-6-sulfonic acid) 라디칼 활성은 13.9 ~ 25.4 ㎎ 트로록스 당량(trolox equivalent)/ g 시료(g sample)의 수수 통곡 추출물 또는 3.9 ~ 4.7 ㎎ 트로록스 당량(trolox equivalent)/ g 시료(g sample) 수수 알곡 추출물보다 3 ~ 25 배 높은 추출물을 수득할 수 있다.
As can be seen in Figure 1, the ABTS (2,2'-Azino-bis-3-ethylbenzothiazoline-6-sulfonic acid) radical activity was 13.9-25.4 Trolox equivalent / g sample (3.9 ~ 4.7 mg Trolox equivalent) / g sample (g sample) Obtained 3 ~ 25 times higher extract than ginseng extract can do.
또한, 상기 수수는 통상적으로 재배 및 구매할 수 있는 것이라면 특별히 제한하지 않으나, 바람직하게는 기탁기관 농업 유전자원 센터에 2012년 10월 15일에 기탁한 기탁번호 KACC98013P인 수수를 사용할 수 있다.The transfer is not particularly limited as long as it can be normally cultivated and purchased, but it is preferable to use the transfer number KACC98013P deposited on October 15, 2012, to the depository agency Agricultural Genetic Resources Center.
도 2는 여러 품종의 수수 겨 추출물의 항산화 활성 성분 및 항산화 활성 측정 결과인데, 상기 기탁번호 KACC98013P인 수수를 사용할 경우, 다른 품종의 수수를 사용하여 수수 겨 추출물을 추출한 것보다 1.2 ~ 8 배 많은 타닌 및/또는 폴리페놀을 포함하는 수수 겨 추출물을 수득할 수 있다.
FIG. 2 shows the antioxidant activity and antioxidative activity of various varieties of mulberry bran extract. In the case of using the silkworm No. KACC98013P, 1.2 ~ 8 times more tannin And / or < / RTI > polyphenols.
게다가, 상기 수수 겨 추출물은 통상적으로 식물체에 존재할 수 있는 항산화 활성 물질을 포함하는 것이라면 특별히 제한하지 않으나, 바람직하게는 탄닌(tannin), 플라보노이드(flavonoid) 및/또는 폴리페놀(polyphenol)을 포함할 수 있다. In addition, the above-mentioned water-borne chestnut extract is not particularly limited as long as it contains an antioxidative active substance that can be present in a plant, but it may preferably contain tannin, flavonoid and / or polyphenol. have.
또한, 상기 수수 겨 추출물은 타닌을 10 ~ 30 ㎎ 포함할 수 있고, 폴리페놀을 20 ~ 80 ㎎ 포함할 수 있다. In addition, the watercress extract may contain 10 to 30 mg of tannin and 20 to 80 mg of polyphenol.
게다가, 상기 수수 겨 추출물의 항산화 활성은 ABTS 라디칼 활성이 50 ~ 120 ㎎ 트로록스 당량(trolox equivalent)/ g 시료(g sample)일 수 있다. 이는 도 1에서 확인되는 바와 같이, 13.9 ~ 25.4 ㎎ 트로록스 당량(trolox equivalent)/ g 시료(g sample)의 수수 통곡 추출물 또는 3.9 ~ 4.7 ㎎ 트로록스 당량(trolox equivalent)/ g 시료(g sample) 수수 알곡 추출물보다 3 ~ 25 배 높은 수치이다. In addition, the antioxidant activity of the above-mentioned barnyardgrass extract may have an ABTS radical activity of 50-120 mg Trolox equivalent / g sample (g sample). This results in a gross excretion of trolox equivalent / g sample (g / sample) or 3.9 ~ 4.7 mg trolox equivalent / g sample (g sample) of 13.9-25.4 mg, It is 3 ~ 25 times higher than that of Acanthopanax senticosus extract.
또한, 상기 ABTS 라디칼 활성은 도 2에서 확인되는 바와 같이, 다른 품종의 수수를 사용한 수수 겨 추출물보다 기탁번호 KACC98013P인 수수, 밀양1호 또는 밀양4호를 사용한 수수 겨 추출물의 ABTS 라디칼 활성이 1.2 ~ 22 배 높은 수치이다.
As shown in FIG. 2, the ABTS radical activity of the chestnut bark extract, which was obtained from Susungwoo, Milyang 1 or Milyang 4, which has the deposit number KACC98013P, 22 times higher.
상기 항산화제 조성물은 수수 겨 추출물을 포함하는 것이라면 이의 함량을 특별히 제한하지 않으나, 바람직하게는 상기 항산화제 조성물 중량 중 수수 겨 추출물 10 ~ 70 중량% 포함하는 것일 수 있다.
Although the content of the antioxidant composition is not particularly limited as long as it contains the chestnut kernels, the antioxidant composition preferably contains 10 to 70% by weight of the chestnut extract in the weight of the antioxidant composition.
본 발명에 따른 항산화제 조성물은, 각각 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽, 에어로졸 등의 경구형 제형, 외용제, 좌제 또는 멸균 주사용액의 형태로 제형화하여 사용될 수 있다.The antioxidant composition according to the present invention can be formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols or the like, oral preparations, suppositories or sterilized injection solutions according to conventional methods Can be used.
상세하게는, 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제될 수 있다. More specifically, when formulating the composition, it can be prepared using a diluent or an excipient such as a filler, an extender, a binder, a wetting agent, a disintegrant, a surfactant, and the like.
경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 상기 수수 겨 추출물에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘카보네이트(calcium carbonate), 수크로스(sucrose), 락토오스(lactose), 젤라틴 등을 섞어 조제될 수 있다. 또한, 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 사용될 수 있다. Solid formulations for oral administration include tablets, pills, powders, granules, capsules and the like, which may contain at least one excipient such as starch, calcium carbonate, sucrose, (sucrose), lactose, gelatin and the like. In addition to simple excipients, lubricants such as magnesium stearate and talc may also be used.
경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데, 흔히 사용되는 단순 희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. Examples of liquid formulations for oral use include suspensions, solutions, emulsions and syrups. In addition to water and liquid paraffin which are commonly used simple diluents, various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like have.
비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조 제제 및 좌제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜(propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. Formulations for parenteral administration include sterile aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations and suppositories. Examples of the suspending agent include propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like.
좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween)61, 카카오지, 라우린지, 글리세로젤라틴 등이 사용될 수 있다.Examples of the suppository base include witepsol, macrogol, tween 61, cacao paper, laurin, glycerogelatin and the like.
본 발명에 따른 수수 겨 추출물은 환자의 나이, 성별, 체중에 따라 달라질 수 있으나, 일반적으로 0.01 내지 500 ㎎/㎏의 양, 바람직하게는 0.1 내지 100 ㎎/㎏의 양을 일일 1회 내지 수회로 나누어 투여할 수 있다. 또한 수수 겨 추출물의 투여량은 투여경로, 질병의 정도, 성별, 체중, 나이 등에 따라서 증감될 수 있다. 따라서 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다.
The amount of the dungberry extract according to the present invention may vary depending on the age, sex and body weight of the patient, but is generally in the range of 0.01 to 500 mg / kg, preferably 0.1 to 100 mg / kg per day, Can be administered separately. In addition, the dose of the watercress extract may be increased or decreased depending on the route of administration, degree of disease, sex, weight, age, and the like. Accordingly, the dosage is not limited in any way to the scope of the present invention.
본 발명의 수수 겨 추출물을 포함하는 항산화 건강 기능성 식품의 종류에는 특별한 제한은 없다. 또한, 상기 수수 겨 추출물을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알코올 음료 및 비타민 복합제 등이 있으며, 환제, 분말, 과립, 침제, 정제, 캡슐 또는 음료인 형태로 사용할 수 있고 통상적인 의미에서의 건강 기능성 식품을 모두 포함한다. There is no particular limitation on the kind of the antioxidant health functional food including the chestnut extract of the present invention. Examples of the food to which the chestnut extract can be added include dairy products including meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gums, ice cream, Tea, a drink, an alcoholic beverage, and a vitamin complex, and can be used in the form of pills, powders, granules, infusions, tablets, capsules or beverages, and includes health functional foods in a conventional sense.
이때, 식품 또는 음료 중 수수 겨 추출물의 양은, 일반적으로 본 발명의 항산화 건강 기능성 식품의 경우, 항산화 건강 기능성 식품 중량의 0.01 내지 15 중량%로 가할 수 있으며, 건강 음료 조성물의 경우 100 ㎖를 기준으로 0.02 내지 10 g, 바람직하게는 0.3 내지 1 g의 비율로 가할 수 있다.At this time, in the case of the antioxidant health functional food of the present invention, the amount of the dunberry extract in the food or beverage can be generally 0.01 to 15% by weight of the weight of the antioxidant health functional food and 100 ml of the health beverage composition May be added in a proportion of 0.02 to 10 g, preferably 0.3 to 1 g.
본 발명의 건강 음료 조성물은 지시된 비율로 필수 성분으로서 상기 수수 겨 추출물을 함유하는 외에는 액체성분에는 특별한 제한은 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물의 예로는 모노사카라이드(예를 들어, 포도당, 과당 등), 디사카라이드(예를 들어 말토스, 슈크로스 등), 폴리사카라이드(예를 들어 덱스트린, 시클로덱스트린) 등과 같은 통상적인 당 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜을 사용할 수 있다. 상술한 것 이외의 향미제로서 천연 향미제 (타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진 등)) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. The health beverage composition of the present invention is not particularly limited to a liquid component other than the above-mentioned water-borne chestnut extract as an essential ingredient in the indicated ratio, and may contain various flavors or natural carbohydrates as an additional ingredient such as ordinary beverages . Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose, etc., disaccharides such as maltose, sucrose, etc., polysaccharides such as dextrin and cyclodextrin Conventional sugars and sugar alcohols such as xylitol, sorbitol, and erythritol can be used. As natural flavors other than those described above, natural flavors (such as tau martin, stevia extract (e.g., rebaudioside A, glycyrrhizin)) and synthetic flavors (saccharin, aspartame, etc.) have.
상기 외에 본 발명의 건강 기능성 식품은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다.In addition to the above, the health functional food of the present invention may contain various kinds of nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, colorants and heavies (cheese, chocolate etc.), pectic acid and its salts, And salts thereof, organic acids, protective colloid thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks, and the like.
그밖에 본 발명의 건강 기능성 식품들은 천연 과일 쥬스, 과일 쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다.
In addition, the health functional foods of the present invention may contain flesh for the production of natural fruit juice, fruit juice beverage and vegetable beverage. These components may be used independently or in combination.
나아가, 본 발명은 수수 겨 및 추출 용매를 혼합하여 혼합물을 제조하는 1단계; 및 상기 혼합물에서 추출물을 추출하는 2단계;를 포함하는 수수 겨 추출물 제조방법을 제공한다.
Further, the present invention relates to a process for producing a mixture comprising: a first step of mixing a bran and an extraction solvent to prepare a mixture; And a second step of extracting the extract from the mixture.
먼저, 1단계로 수수 겨 및 추출 용매를 혼합하여 혼합물을 제조한다.First, the mixture is prepared by mixing the bran and extraction solvent in one step.
상기 수수 겨 및 추출 용매로 혼합비는 통상적으로 식물 추출물 제조에 사용되는 것이라면 특별히 제한하지 않으나, 바람직하게는 수수 겨 100 중량부에 대하여 추출 용매 50 ~ 1,000 중량부를 혼합할 수 있으며, 보다 바람직하게는 수수 겨 100 중량부에 대하여 70 ~ 500 중량부를 혼합할 수 있다.The mixing ratio of the above-mentioned water-extracting and extracting solvent is not particularly limited as long as it is conventionally used for the production of plant extract. Preferably, 50 to 1,000 parts by weight of the extraction solvent may be mixed with 100 parts by weight of water- And 70 to 500 parts by weight based on 100 parts by weight of the bran.
또한, 상기 추출 용매는 통상적으로 식물 추출물 제조에 사용되는 것이라면 특별히 제한하지 않으나, 바람직하게는 아세톤, 저급 알코올 및 물로 이루어진 군 중 1종 이상을 사용할 수 있으며, 더욱 바람직하게는 아세톤 또는 에탄올을 사용할 수 있다.The extraction solvent is not particularly limited as long as it is conventionally used in the production of plant extracts. Preferably, one or more of acetone, lower alcohol and water may be used. More preferably, acetone or ethanol may be used. have.
실험예 3-3의 표 1에서 확인되는 바와 같이, 에탄올 또는 아세톤을 추출 용매로 사용하는 것이 헥산을 추출 용매로 사용하는 것보다 바람직하며, 가장 바람직하게는 에탄올을 사용하여 추출한 수수 겨 추출물이 항산화 활성 및 항산화 활성 물질이 다량 포함하고 있는 것을 알 수 있었다.
As shown in Table 1 of Experimental Example 3-3, the use of ethanol or acetone as the extraction solvent is preferable to the use of hexane as the extraction solvent, and the most preferred ethanol extract is the antioxidant It was found that a large amount of active and antioxidant active substances were contained.
다음으로, 2단계는 상기 혼합물에서 추출물을 추출한다.Next, step 2 extracts the extract from the mixture.
상기 추출물을 추출하는 방법은 통상적으로 식물 추출물 제조에 사용되는 방법이라면 특별히 제한하지 않으나, 바람직하게는 수수 겨에 포함되어 있는 항산화 활성 물질을 추출해내기 위해 진탕 추출, 초음파 추출, 환류 추출 및 정치 추출로 이루어진 군 중 1종의 방법으로 추출될 수 있으며, 더욱 바람직하게는 진탕 추출 또는 초음파 추출을 사용하여 추출할 수 있으며, 가장 바람직하게는 초음파 추출할 수 있다.
The method for extracting the above extract is not particularly limited as long as it is a method used for preparing a plant extract. Preferably, the extract is subjected to shaking extraction, ultrasonic extraction, reflux extraction, and political extraction And more preferably, it can be extracted by shaking extraction or ultrasonic extraction, and most preferably, ultrasonic extraction can be performed.
또한, 상기 추출 방법 중 초음파 추출 방법을 사용하여 추출할 경우, 바람직하게는 40 ~ 80 ㎐의 초음파 및 1 ~ 5 시간 동안 추출할 수 있다.In addition, in the case of extracting using the ultrasonic extraction method among the above extraction methods, it is preferable to extract ultrasonic waves of 40 to 80 Hz and 1 to 5 hours.
만약, 40 ㎐ 미만의 초음파를 사용할 경우, 수수 겨에 함유되어 있는 항산화 활성 및 항산화 활성 물질을 추출하는데 어려운 문제가 발생할 수 있으며, 80 ㎐를 초과하는 초음파를 사용할 경우, 수수 겨에 함유되어 있는 항산화 활성 및 항산화 활성 물질의 파괴가 일어나는 문제가 발생할 수 있다.
If ultrasonic wave of less than 40 ㎐ is used, it may cause difficulties in extracting antioxidant activity and antioxidant activity contained in the bran. When ultrasonic wave exceeding 80 ㎐ is used, the antioxidant activity The active and antioxidant active substances may be destroyed.
더불어, 상기 추출 방법 중 진탕 추출 방법을 사용하여 추출할 경우, 바람직하게는 15 ~ 60 ℃에서 24 ~ 96 시간 동안 진탕 배양하여 추출할 수 있다.In addition, in the case of extracting using the shaking extraction method among the above extraction methods, shaking culture can preferably be carried out at 15 to 60 ° C for 24 to 96 hours.
만약, 15 ℃ 미만의 온도에서 진탕 배양을 수행할 경우, 수수 겨에 함유되어 있는 항산화 활성 및 항산화 활성 물질의 추출 수율이 낮아지는 문제가 발생할 수 있으며, 60 ℃를 초과하는 온도에서 진탕 배양을 수행할 경우, 추출이 수행되는 동안 전분의 호화에 의한 탁도가 증가하거나 항산화 활성 물질 중 열에 약한 성분이 파괴되는 문제가 발생할 수 있다.
If shaking culture is carried out at a temperature lower than 15 캜, there may arise a problem that the antioxidative activity and the extraction yield of the antioxidative active substance contained in the bran are lowered, and the shaking culture is carried out at a temperature exceeding 60 캜 The turbidity due to the starch gelification may increase during the extraction, or the heat-sensitive component of the antioxidant may be destroyed.
이하, 본 발명을 실시예에 의해 상세히 설명하기로 한다. 그러나 이들 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것으로서, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail with reference to examples. However, these examples are intended to further illustrate the present invention, and the scope of the present invention is not limited to these examples.
실시예Example 1. One. 동안메For a while 수수 겨 에탄올 추출물 제조 Manufacture of ethanol extract
기탁기관 농업 유전자원 센터에 2012년 10월 15일에 기탁한 기탁번호 KACC98013P인 신품종 수수인 동안메 수수를 시험구 탈곡기를 이용하여 탈곡하여 알곡을 수득하였다. 이후 알곡을 시험구도정기로 도정하는 과정에서 수득한 과피인 수수 겨 2 g에 100% 에탄올 10 ㎖를 첨가하여 DAIHAN SCIENTIFIC CO. Ltd의 WiseClean 을 이용하여 50 ~ 60 ㎐의 초음파를 사용하여 1시간 초음파추출 후 에탄올 10 ㎖를 더 첨가하여 여과를 거쳐 20 ㎖로 정용하여 동안메 수수 겨 에탄올 추출물을 수득하였다.
The seedlings were thawed using a test stripper during a new variety, KACC98013P, deposited on Oct. 15, 2012, to the Depositor Agricutural Genetic Resource Center to obtain seeds. Then, 10 g of 100% ethanol was added to 2 g of perilla seedlings obtained in the course of preparing the seeds for the period of the test period, and the seeds of DAIHAN SCIENTIFIC CO. Ultrasonic waves of 50 to 60 Hz were used for ultrasonic wave extraction using a WiseClean of Wako Pure Chemical Industries, Ltd., and 10 ml of ethanol was further added thereto. After filtration, the filtrate was diluted to 20 ml to obtain an ethanol extract of rice bran.
실시예Example 2. 2. 동안메For a while 수수 겨 아세톤 추출물 제조 Manufacture of Acetone Extract
추출 용매로 100% 아세톤을 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 동안메 수수 겨 아세톤 추출물을 수득하였다.
A methylated acetone extract was obtained during the same manner as in Example 1, except that 100% acetone was used as the extraction solvent.
실시예Example 3. 진탕 추출물 제조 3. Shindang extract manufacturing
수수 겨에 에탄올을 첨가한 후 25 ℃에서 48시간 동안 진탕 추출하는 과정을 더 수행한 것을 제외하고는 실시예 1과 동일한 방법으로 동안메 수수 겨 진탕 추출물을 수득하였다.The extract was further subjected to shaking extraction at 25 DEG C for 48 hours after addition of ethanol to distilled water.
상기 진탕 추출은 DAIHAN SCIENTIFIC CO. Ltd의 WiseShaker(SHO-2D)를 이용하여 240 ~ 250 RPM의 속도로 진탕 추출하였다.
The shaking extraction was carried out using DAIHAN SCIENTIFIC CO. Shaking at a speed of 240 to 250 RPM using a Wise Shaker (SHO-2D).
비교예Comparative Example 1. One. 동안메For a while 알곡 추출물 Grain extract
실시예 1에서 수득한 동안메 수수의 알곡을 사용하여 추출물을 제조한 것을 제외하고는 실시예 1과 동일한 방법으로 동안메 알곡 추출물을 수득하였다.
A megarad extract was obtained during the same manner as in Example 1, except that the extract was prepared using the horseradish juice during the period obtained in Example 1.
비교예Comparative Example 2. 2. 동안메For a while 통곡 추출물 Myrtle extract
실시예 1의 도정하기 전 동안메 수수의 통곡을 사용하여 추출물을 제조한 것을 제외하고는 실시예 1과 동일한 방법으로 동안메 통곡 추출물을 수득하였다.
A mushroom extract was obtained in the same manner as in Example 1, except that the extract was prepared using the mace of witchcraft during the period before the operation of Example 1.
비교예Comparative Example 3. 3. 황금찰수수A gold rally 겨 추출물 Chestnut extract
동안메 수수 대신 황금찰수수(광복농산에서 구매)를 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 황금찰수수 겨 추출물을 수득하였다.
(Purchased from Kwangbok Agricultural Products Co., Ltd.) was used in place of liquorice, and a golden bran bran extract was obtained in the same manner as in Example 1.
비교예Comparative Example 4. 4. 황금찰수수A gold rally 통곡 추출물 Myrtle extract
비교예 3의 도정하기 전 황금찰수수의 통곡을 사용하여 추출물을 제조한 것을 제외하고는 비교예 3과 동일한 방법으로 황금찰수수 통곡 추출물을 수득하였다.
A golden wilt extract was obtained in the same manner as in Comparative Example 3, except that the extract was prepared using the wreaths of gold wool before compaction of Comparative Example 3.
비교예Comparative Example 5. 5. 황금찰수수A gold rally 알곡 추출물 Grain extract
비교예 3에서 수득한 황금찰수수의 알곡을 사용하여 추출물을 제조한 것을 제외하고는 비교예 3과 동일한 방법으로 황금찰수수 알곡 추출물을 수득하였다.
A golden wilt extract was obtained in the same manner as in Comparative Example 3, except that the extract was prepared using the golden wax obtained in Comparative Example 3.
비교예Comparative Example 6. 6. 동안메For a while 수수 겨 Bite 헥산Hexane 추출물 extract
추출 용매로 헥산(hexane)을 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 동안메 수수 겨 헥산 추출물을 수득하였다.
The hexane extract was obtained during the same manner as in Example 1, except that hexane was used as the extraction solvent.
비교예Comparative Example 7. 7. 밀양2호Miryang No.2 겨 추출물 Chestnut extract
동안메 수수 대신 밀양2호를 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 밀양2호 겨 추출물을 수득하였다.
Except for using Milyang No. 2 instead of Mishyu, the extract of Milyang 2 was obtained in the same manner as in Example 1.
비교예Comparative Example 8. 8. 흰찰수수White chimney 겨 추출물 Chestnut extract
동안메 수수 대신 흰찰수수(괴산잡곡에서 구매)를 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 흰찰수수 겨 추출물을 수득하였다.
White rye bran extract was obtained in the same manner as in Example 1 except that white rye (purchased from Goesan) was used instead of ryegrass.
비교예Comparative Example 9. 9. 밀양1호Milyang 1 겨 추출물 Chestnut extract
동안메 수수 대신 밀양1호를 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 밀양1호 겨 추출물을 수득하였다.
Except for using Milyang No. 1 instead of Mishyu, the same procedure as in Example 1 was carried out.
비교예Comparative Example 10. 10. 밀양4호Milyang 4th 겨 추출물 Chestnut extract
동안메 수수 대신 밀양4호를 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 밀양4호 겨 추출물을 수득하였다.
Except that Milyang 4 was used instead of Maceae. The extracts of Milyang 4 and 5 were obtained in the same manner as in Example 1.
실험예Experimental Example 1. 항산화 활성 측정 1. Antioxidant activity measurement
실시예 1 및 비교예 1 내지 5에서 수득한 수수 추출물들의 항산화 활성을 알아보기 위해 ABTS 라디컬 소거활성을 측정하였다.The ABTS radical scavenging activity of the extracts obtained in Example 1 and Comparative Examples 1 to 5 was measured in order to examine the antioxidative activity.
상기 ABTS 라디컬 소거활성은 ABTS cation decolorization assay 방법에 의하여 측정하였다. ABTS(2,2'-Azino-bis-3-ethylbenzo-thiazoline-6-sulfonic acid) 7.4 mM 및 2.6 mM 과황산칼륨(potassium persulphate)을 혼합한 ABTS 용액을 하루 동안 암소에 방치하여 ABTS 양이온을 형성시킨 후 상기 ABTS 용액을 735 ㎚에서 흡광도 값이 1.4 ~ 1.5가 되도록 몰 흡광계수(ε=3.6×104 M-1cm-1)를 이용하여 에탄올로 희석하였다. 희석한 ABTS 용액 1 ㎖에 상기 수수 추출물 50 ㎕를 첨가하고 30분 후 흡광도의 변화를 측정하였다. 측정한 ABTS 항산화 활성은 도면 1에 나타냈다.The ABTS radical scavenging activity was measured by the ABTS cation decolorization assay. ABTS (2,2'-Azino-bis-3-ethylbenzo-thiazoline-6-sulfonic acid) 7.4 mM and 2.6 mM potassium persulphate were allowed to stand in the dark for one day to form ABTS cations And the ABTS solution was diluted with ethanol using molar extinction coefficient (ε = 3.6 × 10 4 M -1 cm -1 ) such that the absorbance value was 1.4 to 1.5 at 735 nm. To 1 ml of the diluted ABTS solution, 50 쨉 l of the extract was added and after 30 minutes, the change in absorbance was measured. The measured ABTS antioxidant activity is shown in FIG.
도 1에서 확인되는 바와 같이, 황금찰수수 및 동안메 수수 모두 알곡 추출물(비교예 1 및 비교예 5), 통곡 추출물(비교예 2 및 비교예 4), 겨 추출물(실시예 1 및 비교예 3)의 순으로 항산화 활성을 나타내었으며, 알곡 추출물에 비하여 통곡 추출물에서 3 ~ 6배, 통곡 추출물에 비하여 수수 겨 추출물에서 3 ~ 4배 높은 활성을 나타내는 것을 확인할 수 있었다. 특히, 동안메 수수 겨 추출물는 황금찰수수 통곡 추출물에 비하여 7.4배, 동안메 수수 통곡 추출물에 비하여 4.0배 높은 항산화 활성을 보였다.(Comparative Example 1 and Comparative Example 5), fern extract (Comparative Example 2 and Comparative Example 4), bran extract (Example 1 and Comparative Example 3) , Respectively. The antioxidant activity was shown to be 3 ~ 6 times higher in weevil extract and 3 ~ 4 times higher than weevil extract in comparison with weevil extract. Especially, the extracts of P. japonicus showed 7.4 times higher antioxidant activity than the extracts of P. japonicum.
상기 결과를 통해 알 수 있듯이, 수수 겨 추출물이 수수 알곡 추출물 및 수수 통곡 추출물에 비해 높은 항산화 활성을 보였으며, 이로 인해 수수의 항산화 활성을 이용하기 위해서는 알곡 또는 통곡보다 수수의 겨를 이용하는 것이 보다 바람직한 것을 알 수 있었다.
As can be seen from the above results, the mulberry extract had higher antioxidative activity than the mulberry extract and the mulberry extract. Therefore, in order to utilize the antioxidative activity of the mulberry tree, it is more preferable to use millet Could know.
실험예Experimental Example 2. 품종별 항산화 물질 및 항산화 성분의 함량 측정 2. Determination of antioxidant and antioxidant contents
실시예 1, 비교예 3 및 비교예 7 내지 10에서 수득한 수수 겨 추출물들의 항산화 물질인 탄닌(tannin) 및 폴리페놀(polyphenol)의 함량을 측정하였다.The contents of tannin and polyphenol, which are antioxidants, of the bamboo extracts obtained in Example 1, Comparative Example 3 and Comparative Examples 7 to 10 were measured.
총 폴리페놀(polyphenol) 함량은 폴린-시오칼토 페놀 시약(Folin-Ciocalteu phenol reagent)가 상기 수수 겨 추출물의 폴리페놀성 화합물에 의해 환원된 결과 몰리브덴 청색으로 발색하는 것을 원리로 분석하였다. 상기 수수 겨 추출물 50 ㎕에 2% Na2CO3 용액 1 ㎖를 가한 후 3분간 방치하고, 이후 50% Folin-Ciocalteu reagent(Sigma-Aldrich, St. Louis, MO, USA) 50 ㎕를 가하여 반응액을 제조하였다. 이후 30분 후, 상기 반응액의 흡광도 값을 750 ㎚에서 측정하였고, 표준물질인 갈산(gallic acid; Sigma-Aldrich사 제품)를 사용하여 검량선을 작성하였으며, ㎎ 갈산 당량(gallic acid equivalent; GAE)/g(건조 시료; dry basis)로 나타내었다. The total polyphenol content was analyzed on the principle that the Folin-Ciocalteu phenol reagent was reduced to molybdenum blue as a result of being reduced by the polyphenolic compound of the above-mentioned extract. 50 μl of a 50% Folin-Ciocalteu reagent (Sigma-Aldrich, St. Louis, Mo., USA) was added to 50 μl of the above-described watercress extract and 1 ml of a 2% Na 2 CO 3 solution was added thereto. . After 30 minutes, the absorbance of the reaction solution was measured at 750 nm. A calibration curve was prepared using gallic acid (manufactured by Sigma-Aldrich) as a standard, and a gallic acid equivalent (GAE) / g (dry sample) on a dry basis.
총 탄닌(tannin) 함량은 탄닉산(tannic acid)를 표준물질로 하여 검량선을 작성하였다. 즉, 상기 수수 겨 추출물 1 ㎖에 95% 에탄올(ethanol) 1 ㎖ 및 증류수 1 ㎖를 가하여 잘 흔들어 주었다. 이후 5% Na2CO3 용액 1 ㎖ 및 1 N Folin-ciocalteu reagent 0.5 ㎖를 가한 후 실온에서 60분간 발색시킨 다음 725 ㎚에서 흡광도를 측정하였다. The total tannin content was calculated using tannic acid as a standard. That is, 1 ml of 95% ethanol and 1 ml of distilled water were added to 1 ml of the above-mentioned chestnut extract, and the mixture was shaken well. Then, 1 ml of 5% Na 2 CO 3 solution and 0.5 ml of 1 N Folin-ciocalteu reagent were added and developed for 60 minutes at room temperature. Then, the absorbance was measured at 725 nm.
항산화 활성은 ABTS cation decolorization assay방법에 의하여 측정하였으며, 상기 실험예 1과 동일한 방법으로 수행하였다.The antioxidant activity was measured by the ABTS cation decolorization assay and the same procedure as in Experimental Example 1 was carried out.
측정한 폴리페놀, 탄닌 및 항산화 활성 결과는 도면 2에 나타냈다.The measured polyphenol, tannin and antioxidant activity results are shown in FIG.
도 2에서 확인되는 바와 같이, 모든 품종 중에서 동안메 수수 겨 추출물(실시예 1)이 가장 높은 ABTS 항산화 활성을 나타내며, 황금찰수수 겨 추출물(비교예 3)의 1.9배, 흰찰수수 겨 추출물(비교예 8)의 22배 높은 것을 확인할 수 있었다. As can be seen in FIG. 2, the highest concentration of ABTS antioxidant activity was found in all of the varieties (Example 1), 1.9 times of the extract of Golden Rice bran extract (Comparative Example 3), white raspberry bark extract 8).
또한, Tannin 및 polyphenol 함량도 ABTS 항산화활성과 같은 경향을 보여 동안메 수수 겨 추출물(실시예 1)이 황금찰수수 겨 추출물(비교예 3)에 비하여 약 1.9배, 흰찰수수 겨 추출물(비교예 8)의 8배 많이 포함하는 것을 확인할 수 있었다.
In addition, the content of tannin and polyphenol also showed the same tendency as that of ABTS antioxidant activity, while the extract of mackerel bark (Example 1) was about 1.9 times higher than that of gold bell pepper extract (Comparative Example 3) Which is 8 times as many as that of the conventional method.
상기 결과를 통해, 동안메 수수는 다른 품종에 비해 뛰어나게 높은 항산화 활성 및 다량의 항산화 활성 물질을 포함하는 것을 알 수 있었다. 따라서, 수수의 항산화 활성을 이용하기에 적합한 품종은 동안메 수수가 가장 바람직하다는 것이라는 점을 확인할 수 있었다.
From the above results, it can be seen that, during the period, it contains an antioxidant activity and a large amount of antioxidant active substance which are superior to other varieties. Therefore, it was confirmed that the most suitable variety to use the antioxidant activity of sorghum was the most preferable.
실험예Experimental Example 3. 유기용매별 추출 효율 측정 3. Measurement of organic solvent extraction efficiency
실시예 1 내지 2 및 비교예 6에서 수득한 동안메 수수 겨 에탄올 추출물, 동안메 수수 겨 아세톤 추출물 및 동안메 수수 겨 헥산 추출물(이하, '수수 겨 추출물들'로 통칭함)의 추출 효율을 측정하였다.
The extraction efficiency of the methanol extract, the methanol extract and the methanol extract during the period from the results of Examples 1 and 2 and Comparative Example 6 (hereinafter collectively referred to as the "water extracts") were measured Respectively.
실험예Experimental Example 3-1: 항산화 활성 물질 함유량 측정 3-1: Measurement of content of antioxidant active substance
상기 수수 겨 추출물들에 포함되어 있는 폴리페놀의 함량은 상기 실험예 2와 동일한 방법으로 측정하였고, 측정 결과는 도면 3에 나타냈다.The content of polyphenol contained in the above-mentioned watercress extracts was measured in the same manner as in Experimental Example 2, and the measurement results are shown in FIG.
또한, 플라보노이드의 함량은 추출물 250 ㎕에 증류수 1 ㎖와 5% NaNO₂75 ㎕를 가한 다음, 5분 후 10% AlCl₃6H2O 150 ㎕를 가하여 6분 방치하고 1 N NaOH 500 ㎕를 가하였다. 11분 후, 반응액의 흡광도 값을 510 ㎚에서 측정하였다. 표준물질인 (+)-catechin(Sigma-Aldrich)를 사용하여 검량선을 작성하였으며, ㎎ catechin equivalent(CE)/g(dry basis)로 나타내는 방법으로 측정하였고, 측정 결과는 도면 3에 나타냈다.The content of flavonoid was determined by adding 1 ml of distilled water and 75 μl of 5% NaNO 2 to 250 μl of the extract, adding 150 μl of 10% AlCl 3 6H 2 O 5 minutes, allowing to stand for 6 minutes, and adding 500 μl of 1 N NaOH. After 11 minutes, the absorbance of the reaction solution was measured at 510 nm. The calibration curve was prepared using a standard substance (+) - catechin (Sigma-Aldrich) and measured by a method represented by mg catechin equivalent (CE) / g (dry basis). The measurement results are shown in FIG.
도 3에서 확인되는 바와 같이, 에탄올을 사용하여 추출한 실시예 1의 동안메 수수 겨 에탄올 추출물이 아세톤(실시예 2)에 비해 1.1 ~ 1.3배, 헥산(비교예 6)에 비해 5 ~ 10배 다량의 폴리페놀 및 플라보노이드를 포함하는 것을 확인할 수 있었다. 또한, 아세톤을 사용하여 추출한 수수 겨 추출물(실시예 2)는 헥산을 사용하여 추출한 수수 겨 추출물(비교예 6)에 비해 5 ~ 8배 많은 폴리페놀 및 플라보노이드를 포함하는 것을 확인할 수 있었다.
As can be seen in FIG. 3, during the extraction of Example 1 using ethanol, the ethanol extract of Mugwort was 1.1 to 1.3 times higher than that of acetone (Example 2) and 5 to 10 times higher than that of hexane (Comparative Example 6) Of polyphenols and flavonoids. In addition, it was confirmed that the Acanthopanax senticosus extract (Example 2) extracted with acetone contained 5 to 8 times more polyphenols and flavonoids than the Acanthopelust extract extracted with hexane (Comparative Example 6).
실험예Experimental Example 3-2: 항산화 활성 측정 3-2: Antioxidant activity measurement
상기 수수 겨 추출물들의 항산화 활성을 측정하기 위해 ABTS 항산화 활성 및 DPPH 항산화 활성을 측정하였다.The antioxidative activity and DPPH antioxidant activity of ABTS were measured in order to measure the antioxidative activity of the above - mentioned.
ABTS 항산화 활성은 상기 실험예 1과 동일한 방법으로 수행하였다. 또한, DPPH 항산화 활성은 0.2 mM DPPH용액(99.9% 에탄올에 용해) 0.8 ㎖에 시료 0.2 ㎖를 첨가한 후 520 ㎚에서 정확히 30분 후에 흡광도의 변화를 측정하였다. DPPH radical의 소거활성은 ㎎ TE(Trolox equivalent antioxidant capacity)/g(dry basis)으로 표현하는 방법으로 측정하였다. 측정한 항산화 활성은 도면 4에 나타냈다.The antioxidative activity of ABTS was performed in the same manner as in Experimental Example 1 above. In addition, DPPH antioxidant activity was measured by adding 0.2 ml of a 0.2 mM DPPH solution (dissolved in 99.9% ethanol) to 0.2 ml of the sample, and then measuring the absorbance at 520 nm exactly after 30 minutes. The scavenging activity of DPPH radicals was measured by the method expressed in mg TE (Trolox equivalent antioxidant capacity) / g (dry basis). The measured antioxidant activity is shown in Fig.
도 4에서 확인되는 바와 같이, 에탄올을 사용하여 추출한 실시예 1의 동안메 수수 겨 에탄올 추출물이 아세톤(실시예 2)에 비해 1.4 ~ 2.0배 높은 항산화 활성을 확인할 수 있었다. 또한, 헥산을 이용하여 추출한 수수 겨 추출물(비교예 6)은 ABTS 항산화 활성 및 DPPH 항산화 활성 측정방법에서 항산화 활성이 측정되지 않았다.
As can be seen from FIG. 4, the ethanol extract of the rice celery during the extraction of Example 1 using ethanol showed an antioxidative activity 1.4-2.0 times higher than that of acetone (Example 2). In addition, antioxidative activity was not measured in the method of measuring ABTS antioxidant activity and DPPH antioxidant activity of the chestnut extract (Comparative Example 6) extracted with hexane.
실험예Experimental Example 3-3: 추출 효율 측정 3-3: Measurement of extraction efficiency
상기 수수 겨 추출물들의 추출 효율을 수수겨 10g을 사용한 것을 제외하고는 실시예 1 내지 2 및 비교예 6과 동일한 방법으로 추출 후 추출액을 감압건조와 동결건조과정을 거쳐 잔류물의 무게를 측정하는 방법으로 계산하였다. 계산한 추출 효율은 하기 표 1에 나타냈다.A method of measuring the weight of the residue by subjecting the extracted extract to vacuum drying and freeze-drying processes in the same manner as in Examples 1 to 2 and Comparative Example 6, except that 10 g of the extracting efficiency of the above-mentioned barnyardgrass extracts was used Respectively. The calculated extraction efficiencies are shown in Table 1 below.
(추출 용매: 에탄올)Example 1
(Extraction solvent: ethanol)
(추출 용매: 아세톤)Example 2
(Extraction solvent: acetone)
(추출 용매: 헥산)Comparative Example 6
(Extraction solvent: hexane)
상기 표 1에서 확인되는 바와 같이, 추출 용매로 에탄올을 사용하여 추출물을 추출한 실시예 1이 아세톤 또는 헥산을 사용한 것보다 추출 효율이 높은 것을 확인할 수 있었으며, 아세톤을 사용하여 추출물을 추출한 실시예 2는 헥산을 추출 용매로 사용한 비교예 6보다 1.3배 높은 추출 효율을 보였다.
As shown in Table 1, it was confirmed that the extraction efficiency of Example 1 in which the extract was extracted using ethanol as the extraction solvent was higher than that in the case of using acetone or hexane, and Example 2 in which the extract was extracted using acetone Extraction efficiency was 1.3 times higher than that of Comparative Example 6 using hexane as an extraction solvent.
상기 실험들을 통해 알 수 있듯이, 수수의 항산화 물질 추출 용매로는 에탄올을 사용하는 것이 가장 바람직하며, 아세톤 또한 수수 겨의 항산화 물질을 추출하는데 바람직한 것을 확인할 수 있었다.
As can be seen from the above experiments, ethanol is the most preferable solvent for extracting antioxidants, and acetone is also preferable for extracting antioxidants.
실험예Experimental Example 4. 추출방법별 항산화 활성 및 폴리페놀 함량 측정 4. Determination of antioxidant activity and polyphenol content by extraction method
실시예 1 및 실시예 3에서 수득한 수수 겨 추출물의 ABTS 항산화 활성 및 폴리페놀 함량을 측정하였다.The ABTS antioxidant activity and polyphenol content of the cherry safflower extract obtained in Example 1 and Example 3 were measured.
상기 ABTS 항산화 활성은 상기 실험예 1과 동일한 방법으로 수행하였고, 폴리페놀 함량은 상기 실험예 2와 동일한 방법으로 측정하였다. 측정한 ABTS 항산화 활성 및 폴리페놀 함량은 도면 5에 나타냈다.The ABTS antioxidant activity was measured in the same manner as in Experimental Example 1, and the polyphenol content was measured in the same manner as in Experimental Example 2. The measured ABTS antioxidant activity and polyphenol content are shown in FIG.
도 5에서 확인되는 바와 같이, 진탕 추출하여 수득한 추출물(실시예 3)에 비하여 초음파 추출하여 수득한 추출물(실시예 1)이 약 1.2 ~ 1.3 배 많은 항산화 활성 성분(폴리페놀) 및 항산화 활성(ABTS 항산화 활성)이 증가한 것을 확인할 수 있었다.As shown in Fig. 5, the antioxidative activity component (polyphenol) and the antioxidant activity (antioxidant activity) of the extract (Example 1) obtained by ultrasonic extraction compared to the extract obtained by shaking (Example 3) ABTS antioxidant activity) was increased.
따라서, 수수의 항산화 활성 물질을 추출하는 방법으로는 초음파 추출이 진탕 추출보다 바람직한 것을 알 수 있었다.
Therefore, it was found that ultrasonic extraction is preferable to shaking extraction as a method of extracting an antioxidative active substance.
실시예, 비교예 및 실험예를 통해 확인할 수 있듯이, 수수의 항산화 활성 물질인 폴리페놀, 폴리플라보노이드 및 탄닌은 통곡 또는 알곡에 비해 수수 겨에 다량 함유되어 있는 것을 확인할 수 있었다. 또한, 수수에서 항산화 활성 물질을 추출하는 용매로는 에탄올이 가장 바람직하며, 아세톤도 수수의 항산화 활성 물질을 추출하는데 바람직한 것을 알 수 있었다. 나아가, 여러 품종의 수수 중 동안메 수수, 밀양1호 및 밀양4호에 항산화 활성 물질이 다량 함유되어 있어 이들을 활용하여 수수의 항산화 활성 물질을 얻는 것이 바람직하며, 또한 이 중 동안메 수수를 사용하는 것이 가장 바람직한 것을 확인할 수 있었다. 게다가, 수수의 항산화 활성 물질을 추출하는 방법에는 초음파 추출이 진탕 추출하는 것이 더 바람직한 것을 알 수 있었다.
As can be seen from Examples, Comparative Examples and Experimental Examples, it was confirmed that polyphenols, polyflavonoids and tannins, which are antioxidative active substances, are contained in a large amount in the shrubs than in the weevil or wheat. In addition, ethanol is the most preferable solvent for extracting antioxidative active materials from sorghum, and it is found that acetone is preferable for extracting antioxidative active substances. Furthermore, it is desirable to obtain antioxidative active substances by using these antioxidative active substances in a large amount of antioxidative active substances in Mesosu, Milyang 1 and Milyang 4 during the transplanting of various varieties. In addition, Was most preferable. In addition, it has been found that, in the method of extracting a fermented antioxidative active substance, it is more preferable to perform shaking extraction with ultrasonic extraction.
[[ 제조예Manufacturing example ]]
제조예Manufacturing example 1 : 약학적 조성물의 제조 1: Preparation of pharmaceutical composition
수수 겨 추출물을 포함하는 약학적 조성물의 제제예를 설명하나, 본 발명은 이를 한정하고자 함이 아닌 단지 구체적으로 설명하고자 함이다.An example of a pharmaceutical composition containing a chaff endowed extract is described, but the present invention is not intended to be limited thereto but is specifically described.
하기 제조예에서 사용한 수수 겨 추출물은 실시예 1에서 제조한 동안메 수수 겨 추출물을 사용하였다.
The chestnut extract used in the following preparation example was prepared by the same method as in Example 1 except that the extract was used.
제조예Manufacturing example 1-1. 1-1. 산제의Sanje 제조 Produce
실시예 1의 수수 겨 추출물 2 g2 g < RTI ID = 0.0 >
유당 1 gLactose 1 g
상기의 성분을 혼합하고 기밀포에 충진하여 산제를 제조하였다.
The above components were mixed and packed in airtight bags to prepare powders.
제조예Manufacturing example 1-2. 정제의 제조 1-2. Manufacture of tablets
실시예 1의 수수 겨 추출물 100 ㎎100 mg of the bran extract of Example 1
옥수수전분 100 ㎎
유 당 100 ㎎100 mg of milk
스테아린산 마그네 2 ㎎Magnesium stearate 2 mg
상기의 성분을 혼합한 후, 통상의 정제의 제조방법에 따라서 타정하여 정제를 제조하였다.
After mixing the above components, tablets were prepared by tableting according to a conventional method for producing tablets.
제조예Manufacturing example 1-3. 캡슐제의 제조 1-3. Preparation of capsules
실시예 1의 수수 겨 추출물 100 ㎎100 mg of the bran extract of Example 1
옥수수전분 100 ㎎
유 당 100 ㎎100 mg of milk
스테아린산 마그네슘 2 ㎎2 mg of magnesium stearate
상기의 성분을 혼합한 후, 통상의 캡슐제의 제조방법에 따라서 젤라틴 캡슐에 충전하여 캡슐제를 제조하였다.
After mixing the above components, the capsules were filled in gelatin capsules according to the conventional preparation method of capsules.
제조예Manufacturing example 1-4. 환의 제조 1-4. Manufacture of rings
실시예 1의 수수 겨 추출물 1 g1 g < RTI ID = 0.0 >
유당 1.5 gLactose 1.5 g
글리세린 1 gGlycerin 1 g
자일리톨 0.5 g0.5 g of xylitol
상기의 성분을 혼합한 후, 통상의 방법에 따라 1환 당 4 g이 되도록 제조하였다.
After mixing the above components, they were prepared so as to be 4 g per one ring according to a conventional method.
제조예Manufacturing example 2 : 건강 기능성 식품의 제조. 2: Preparation of health functional foods.
본 발명의 수수 겨 추출물을 포함하는 건강 기능성 식품의 제조예를 설명하나, 본 발명은 이를 한정하고자 함이 아닌 단지 구체적으로 설명하고자 함이다.The preparation of a health functional food containing the chestnut extract of the present invention will be described, but the present invention is not intended to be limited thereto but is specifically explained.
하기 제조예에서 사용한 수수 겨 추출물은 실시예 1에서 제조한 동안메 수수 겨 추출물을 사용하였다.
The chestnut extract used in the following preparation example was prepared by the same method as in Example 1 except that the extract was used.
제조예Manufacturing example 2-1. 건강 기능성 식품의 제조 2-1. Manufacture of Health Functional Foods
실시예 1의 수수 겨 추출물 3000 ㎎3000 mg of the bran extract of Example 1
비타민 A 아세테이트 70 ㎍70 [mu] g of vitamin A acetate
비타민 E 1.0 ㎎Vitamin E 1.0 mg
비타민 B1 0.13 ㎎0.13 mg vitamin B1
비타민 B2 0.15 ㎎0.15 mg of vitamin B2
비타민 C 10 ㎎10 mg vitamin C
비오틴 10 ㎍Biotin 10 μg
엽산 50 ㎍50 ㎍ of folic acid
판토텐산 칼슘 0.5 ㎎Calcium pantothenate 0.5 mg
황산제1철 1.75 ㎎1.75 mg of ferrous sulfate
산화아연 0.82 ㎎0.82 mg of zinc oxide
탄산마그네슘 25.3 ㎎Magnesium carbonate 25.3 mg
제1인산칼륨 15 ㎎15 mg of potassium phosphate monobasic
구연산칼륨 90 ㎎
상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 건강식품에 적합한 성분을 바람직한 제조예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 건강식품 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강식품 조성물 제조에 사용할 수 있다.
Although the composition ratio of the above-mentioned vitamin and mineral mixture is relatively mixed with a suitable preparation for health food, the compounding ratio may be arbitrarily changed, and the above ingredients may be mixed according to a conventional method for producing healthy food , Granules can be prepared and used in the manufacture of health food compositions according to conventional methods.
제조예Manufacturing example 2-2. 건강 음료의 제조 2-2. Manufacture of health drinks
실시예 1의 수수 겨 추출물 3 g3 g < RTI ID = 0.0 >
구연산 1000 ㎎Citric acid 1000 mg
올리고당 100 g100 g of oligosaccharide
매실농축액 2 gPlum concentrate 2 g
타우린 1 gTaurine 1 g
정제수를 가하여 전체 900 ㎖Purified water was added to a total of 900 ml
통상의 건강 음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1시간 동안 85℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2ℓ용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 건강 기능성 음료 조성물 제조에 사용한다.The above components were mixed according to a conventional health drink manufacturing method, and the mixture was heated for about 1 hour at 85 DEG C with stirring, and the solution thus prepared was filtered to obtain a sterilized 2-liter container, which was sealed and sterilized, Of health functional beverage composition.
상기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 제조예로 혼합 조성하였지만 수요계층이나, 수요국가, 사용용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다.
Although the composition ratio is relatively mixed with the ingredients suitable for the favorite beverage as a preferable preparation example, the blending ratio may be arbitrarily modified according to the local or national preference such as the demand class, demand country, use purpose, and the like.
Claims (12)
상기 혼합물에서 추출물을 추출하는 2단계;
를 포함하는 국립농업과학원 농업유전자원센터 기탁번호 KACC98013P의 수수 겨 추출물 제조방법.The first step of preparing a mixture by mixing the bran and extraction solvent of KACC 98013P, National Institute of Agricultural Science and Technology, And
2) extracting the extract from the mixture;
Of the National Institute of Agricultural Science and Technology, National Institute of Agricultural Science and Technology, KACC98013P.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130092788A KR101498075B1 (en) | 2013-08-05 | 2013-08-05 | Composition and health functional food containing extracts of sorghum bran |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130092788A KR101498075B1 (en) | 2013-08-05 | 2013-08-05 | Composition and health functional food containing extracts of sorghum bran |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150016838A KR20150016838A (en) | 2015-02-13 |
KR101498075B1 true KR101498075B1 (en) | 2015-03-06 |
Family
ID=52573445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130092788A KR101498075B1 (en) | 2013-08-05 | 2013-08-05 | Composition and health functional food containing extracts of sorghum bran |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101498075B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102674571B1 (en) | 2024-03-08 | 2024-06-11 | 김혜빈 | Antioxidant cosmetic composition containing buckwheat honey |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115155101A (en) * | 2022-06-28 | 2022-10-11 | 甘肃省农业科学院畜草与绿色农业研究所(甘肃省农业科学院农业质量标准与检测技术研究所) | Sweet sorghum total flavone optimal extraction method and oxidation resistance evaluation method |
-
2013
- 2013-08-05 KR KR1020130092788A patent/KR101498075B1/en active IP Right Grant
Non-Patent Citations (3)
Title |
---|
Awika, J.M. et al. FOOD CHEMISTRY (2005) vol.90, pp.293-301 * |
Sikwese, F.E. et al. FOOD CHEMISTRY (2007) vol.104, pp.324-331 * |
김정인, 농업기술회보 (2013) vol.50, no.2 p.39 "신품종 소개-항산화 성분이 풍부한 건강기능성 메수수 '동안메'" * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102674571B1 (en) | 2024-03-08 | 2024-06-11 | 김혜빈 | Antioxidant cosmetic composition containing buckwheat honey |
Also Published As
Publication number | Publication date |
---|---|
KR20150016838A (en) | 2015-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101316091B1 (en) | Health assistance food using dendropanax morbifera and manufacturing method thereof | |
KR101413132B1 (en) | Sorhum with extremely high antioxidant activity | |
KR101412057B1 (en) | Composition for preventing or treating aging or cancer comprising Camellia extract as an active ingredient | |
KR101125224B1 (en) | A composition for skin anti-aging comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient | |
KR101498075B1 (en) | Composition and health functional food containing extracts of sorghum bran | |
KR20180098736A (en) | A composition having anti-oxidation or anti-bacterial activity comprising Selaginella tamariscina extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
KR101494664B1 (en) | fermented corni fructus composition with antioxidant activity and method of making the same | |
KR101692889B1 (en) | Composition comprising an extract or a fraction of Daphne kamtschatica for preventing or treating inflammatory diseases | |
KR101063351B1 (en) | The extracts and fractions of Hippophae rhamnoides L. | |
KR20150034025A (en) | Barley sprout tea having increased content of antioxidative or hypoglycemic components | |
KR101399398B1 (en) | Method for manufacturing submerged-state fermented Allium victorialis and Composition for preventing or treating anti-diabetes or anti-diabetic complication containing fermented Allium victorialis | |
KR20160055748A (en) | Barley sprout tea having increased content of antioxidative or hypoglycemic components | |
KR20190124194A (en) | Barley sprout tea having increased content of antioxidative or hypoglycemic components | |
KR101962893B1 (en) | Composition of comprising vegetable worms extract cultured using mealworm or pupa and process of fabrication the extract | |
KR20170077980A (en) | Antioxidant or anti-aging composition comprising extracts of fresh sprouts of Xanthium canadense Mill. | |
KR101891408B1 (en) | A composition comprising ganoderma lucidum grown on hulled barley extracts having anti-oxidation or anti-inflammation activity | |
KR20170059221A (en) | Antioxidant or anti-aging composition comprising the extract of stem and leaf of Rubus coreanus Miquel | |
KR20150037774A (en) | Preparation of clove having enhanced antioxidative effect | |
KR101817053B1 (en) | Composition for anti-oxidant or anti-cancer or anti-obesity or immune-enhancing containing Codonopsis lanceolata extract | |
KR20150085215A (en) | Composition comprising black garlic and Gastrodia elata extract with antioxidant activity and method of making the same | |
KR101425560B1 (en) | Composition for antioxidant comprising extracts or its fractions of Elaeocarpus petiolatus as an active ingredient | |
KR101370679B1 (en) | Method for manufacturing solid-state fermented Allium victorialis and Composition for preventing or treating anti-diabetes or anti-diabetic complication containing fermented Allium victorialis | |
KR101426232B1 (en) | Astringent cosmetic composition containing extract of rice cultivated with Phellinus baumii mycelium as effective component | |
KR101398737B1 (en) | Composition for preventing and/or treating tumor containing component originating in the bark of tree belonging to the genus acacia | |
KR20160017457A (en) | a composition comprising an leaf extract of Chionanthus retusus L. as an active ingredient for preventing or treating aging-involved degenerative disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |